Alembic Pharmaceuticals
APLLTD.NS
$12.28
Share price
2.98%
Change (1 day)
78.75%
Change (1 year)
Categories
Operating Margin for Alembic Pharmaceuticals (APLLTD.NS)
Operating Margin as of May 2024 (TTM): 7.31%
According to Alembic Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 7.31%. At the end of 2022 the company had an Operating Margin of 11.85%.
Operating Margin history for Alembic Pharmaceuticals from 2013 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 11.85% | -54.29% |
| 2021 | 25.93% | 16.49% |
| 2020 | 22.26% | 13.07% |
| 2019 | 19.68% | 10.38% |
| 2018 | 17.83% | 2.86% |
| 2017 | 17.34% | -43.39% |
| 2016 | 30.63% | 71.43% |
| 2015 | 17.86% | 4.68% |
| 2014 | 17.07% | 23.48% |
| 2013 | 13.82% | 25.89% |
| 2012 | 10.98% | 23.2% |
| 2011 | 8.91% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.